{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:37:25Z","timestamp":1787503045507,"version":"build-2736575974"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1038\/nrurol.2010.4","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:08:04Z","timestamp":1265674084000},"page":"127-135","source":"Crossref","is-referenced-by-count":59,"title":["New treatments for chronic prostatitis\/chronic pelvic pain syndrome"],"prefix":"10.1038","volume":"7","author":[{"given":"Adam C.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Dimitrakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"BFnrurol20104_CR1","first-page":"305","volume-title":"Campbell-Walsh Urology","author":"JC Nickel","year":"2007","unstructured":"Nickel, J. C. in Campbell-Walsh Urology 9th edn (eds Wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. W. & Peters, C. A.) 305\u2013329 (Saunders, Philadelphia, 2007)."},{"key":"BFnrurol20104_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0022-5347(01)66359-6","volume":"155","author":"K Wenninger","year":"1996","unstructured":"Wenninger, K., Heiman, J. R., Rothman, I., Berghuis, J. P. & Berger, R. E. Sickness impact of chronic nonbacterial prostatitis and its correlates. J. Urol. 155, 965\u2013968 (1996).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1525-1497.2001.01223.x","volume":"16","author":"M McNaughton Collins","year":"2001","unstructured":"McNaughton Collins, M. et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J. Gen. Intern. Med. 16, 656\u2013662 (2001).","journal-title":"J. Gen. Intern. Med."},{"key":"BFnrurol20104_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/j.1464-410X.2007.07250.x","volume":"100","author":"J Walz","year":"2007","unstructured":"Walz, J. et al. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int. 100, 1307\u20131311 (2007).","journal-title":"BJU Int."},{"key":"BFnrurol20104_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1464-410X.2004.05157.x","volume":"94","author":"DA Tripp","year":"2004","unstructured":"Tripp, D. A., Curtis Nickel, J., Landis, J. R., Wang, Y. L. & Knauss, J. S. Predictors of quality of life and pain in chronic prostatitis\/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU Int. 94, 1279\u20131282 (2004).","journal-title":"BJU Int."},{"key":"BFnrurol20104_CR6","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1464-410X.2008.08157.x","volume":"103","author":"DA Tripp","year":"2009","unstructured":"Tripp, D. A., Nickel, J. C., Ross, S., Mullins, C. & Stechyson, N. Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16\u201319 years. BJU Int. 103, 1080\u20131084 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol20104_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.282.3.236","volume":"282","author":"JN Krieger","year":"1999","unstructured":"Krieger, J. N., Nyberg, L. Jr & Nickel, J. C. NIH consensus definition and classification of prostatitis. JAMA 282, 236\u2013237 (1999).","journal-title":"JAMA"},{"key":"BFnrurol20104_CR8","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1056\/NEJMcp060423","volume":"355","author":"AJ Schaeffer","year":"2006","unstructured":"Schaeffer, A. J. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N. Engl. J. Med. 355, 1690\u20131698 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol20104_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncpuro0003","volume":"1","author":"RB Alexander","year":"2004","unstructured":"Alexander, R. B. Treatment of chronic prostatitis. Nat. Clin. Pract. Urol. 1, 2\u20133 (2004).","journal-title":"Nat. Clin. Pract. Urol."},{"key":"BFnrurol20104_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrurol.2009.197","volume":"6","author":"RB Alexander","year":"2009","unstructured":"Alexander, R. B. Prostatitis: clinical phenotyping of patients with pelvic pain. Nat. Rev. Urol. 6, 531\u2013532 (2009).","journal-title":"Nat. Rev. Urol."},{"key":"BFnrurol20104_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1464-410X.2007.07196.x","volume":"101","author":"JC Nickel","year":"2008","unstructured":"Nickel, J. C. et al. Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis\/chronic pelvic pain syndrome. BJU Int. 101, 59\u201364 (2008).","journal-title":"BJU Int."},{"key":"BFnrurol20104_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1464-410X.2005.05684.x","volume":"96","author":"MA Pontari","year":"2005","unstructured":"Pontari, M. A. et al. A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int. 96, 559\u2013565 (2005).","journal-title":"BJU Int."},{"issue":"Suppl. 1","key":"BFnrurol20104_CR13","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.ijantimicag.2004.02.009","volume":"24","author":"AJ Schaeffer","year":"2004","unstructured":"Schaeffer, A. J. NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int. J. Antimicrob. Agents 24 (Suppl. 1), S49\u2013S52 (2004).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFnrurol20104_CR14","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1056\/NEJMoa0803240","volume":"359","author":"JC Nickel","year":"2008","unstructured":"Nickel, J. C. et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N. Engl. J. Med. 359, 2663\u20132673 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol20104_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00345-003-0327-2","volume":"21","author":"JM Potts","year":"2003","unstructured":"Potts, J. M. Chronic pelvic pain syndrome: a non-prostatocentric perspective. World J. Urol. 21, 54\u201356 (2003).","journal-title":"World J. Urol."},{"issue":"Suppl. 3","key":"BFnrurol20104_CR16","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.3949\/ccjm.74.Suppl_3.S63","volume":"74","author":"J Potts","year":"2007","unstructured":"Potts, J. & Payne, R. E. Prostatitis: infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve. Clin. J. Med. 74 (Suppl. 3), S63\u2013S71 (2007).","journal-title":"Cleve. Clin. J. Med."},{"key":"BFnrurol20104_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/0003-4819-140-8-200404200-00010","volume":"140","author":"CJ Woolf","year":"2004","unstructured":"Woolf, C. J. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann. Intern. Med. 140, 441\u2013451 (2004).","journal-title":"Ann. Intern. Med."},{"key":"BFnrurol20104_CR18","unstructured":"US Department of Health and Human Services US Preventive Services Task Force Grade Definitions [online] , (2009)."},{"key":"BFnrurol20104_CR19","first-page":"1922","volume-title":"Campbell-Walsh Urology","author":"N Yoshimura","year":"2007","unstructured":"Yoshimura, N. & Chancellor, M. in Campbell-Walsh Urology 9th edn (eds Wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. W. & Peters, C. A.) 1922\u20131972 (Saunders, Philadelphia, 2007)."},{"key":"BFnrurol20104_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/S0022-5347(05)66344-6","volume":"165","author":"JC Nickel","year":"2001","unstructured":"Nickel, J. C., Downey, J., Johnston, B. & Clark, J. Predictors of patient response to antibiotic therapy for the chronic prostatitis\/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J. Urol. 165, 1539\u20131544 (2001).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","volume":"141","author":"RB Alexander","year":"2004","unstructured":"Alexander, R. B. et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann. Intern. Med. 141, 581\u2013589 (2004).","journal-title":"Ann. Intern. Med."},{"key":"BFnrurol20104_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0090-4295(03)00583-1","volume":"62","author":"J Nickel","year":"2003","unstructured":"Nickel, J. et al. Levofloxacin for chronic prostatitis\/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62, 614\u2013617 (2003).","journal-title":"Urology"},{"key":"BFnrurol20104_CR23","first-page":"278","volume":"10","author":"X Zeng","year":"2004","unstructured":"Zeng, X. et al. Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis [Chinese]. Zhonghua Nan Ke Xue 10, 278\u2013281 (2004).","journal-title":"Zhonghua Nan Ke Xue"},{"key":"BFnrurol20104_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mehy.2008.10.020","volume":"72","author":"I Tomaskovic","year":"2009","unstructured":"Tomaskovic, I., Ruzic, B., Trnski, D. & Kraus, O. Chronic prostatitis\/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy. Med. Hypotheses 72, 261\u2013262 (2009).","journal-title":"Med. Hypotheses"},{"key":"BFnrurol20104_CR25","first-page":"237","volume":"15","author":"MG Yang","year":"2009","unstructured":"Yang, M. G. et al. Corticoid combined with an antibiotic for chronic nonbacterial prostatitis [Chinese]. Zhonghua Nan Ke Xue 15, 237\u2013240 (2009).","journal-title":"Zhonghua Nan Ke Xue"},{"key":"BFnrurol20104_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/sti.76.5.398","volume":"76","author":"S Bates","year":"2000","unstructured":"Bates, S. & Talbot, M. Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one non-responder. Sex. Transm. Infect. 76, 398\u2013399 (2000).","journal-title":"Sex. Transm. Infect."},{"key":"BFnrurol20104_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.mehy.2005.12.008","volume":"67","author":"AJ Yun","year":"2006","unstructured":"Yun, A. J. & Doux, J. D. Opening the floodgates: benign prostatic hyperplasia may represent another disease in the compendium of ailments caused by the global sympathetic bias that emerges with aging. Med. Hypotheses 67, 392\u2013394 (2006).","journal-title":"Med. Hypotheses"},{"key":"BFnrurol20104_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.pcan.4500561","volume":"5","author":"IE Anglin","year":"2002","unstructured":"Anglin, I. E., Glassman, D. T. & Kyprianou, N. Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis. 5, 88\u201395 (2002).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"BFnrurol20104_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.urology.2005.12.015","volume":"67","author":"JD Dimitrakov","year":"2006","unstructured":"Dimitrakov, J. D., Kaplan, S. A., Kroenke, K., Jackson, J. L. & Freeman, M. R. Management of chronic prostatitis\/chronic pelvic pain syndrome: an evidence-based approach. Urology 67, 881\u2013888 (2006).","journal-title":"Urology"},{"key":"BFnrurol20104_CR30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1464-410X.2003.04766.x","volume":"93","author":"JC Nickel","year":"2004","unstructured":"Nickel, J. C., Downey, J., Pontari, M. A., Shoskes, D. A. & Zeitlin, S. I. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int. 93, 991\u2013995 (2004).","journal-title":"BJU Int."},{"key":"BFnrurol20104_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/01.ju.0000101487.83730.80","volume":"171","author":"SA Kaplan","year":"2004","unstructured":"Kaplan, S. A., Volpe, M. A. & Te, A. E. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis\/chronic pelvic pain syndrome. J. Urol. 171, 284\u2013288 (2004).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.urology.2003.08.006","volume":"63","author":"AF De Rose","year":"2004","unstructured":"De Rose, A. F., Gallo, F., Giglio, M. & Carmignani, G. Role of mepartricin in category III chronic nonbacterial prostatitis\/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology 63, 13\u201316 (2004).","journal-title":"Urology"},{"key":"BFnrurol20104_CR33","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/01.ju.0000159198.83103.01","volume":"173","author":"JC Nickel","year":"2005","unstructured":"Nickel, J. C. et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J. Urol. 173, 1252\u20131255 (2005).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/ecam\/neh128","volume":"2","author":"JL Capodice","year":"2005","unstructured":"Capodice, J. L., Bemis, D. L., Buttyan, R., Kaplan, S. A. & Katz, A. E. Complementary and alternative medicine for chronic prostatitis\/chronic pelvic pain syndrome. Evid. Based Complement. Alternat. Med. 2, 495\u2013501 (2005).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"BFnrurol20104_CR35","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2009.05.046","volume":"56","author":"FM Wagenlehner","year":"2009","unstructured":"Wagenlehner, F. M. et al. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur. Urol. 56, 544\u2013551 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol20104_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.juro.2007.09.088","volume":"179","author":"DA Shoskes","year":"2008","unstructured":"Shoskes, D. A. et al. Muscle tenderness in men with chronic prostatitis\/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J. Urol. 179, 556\u2013560 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0022-5347(01)61802-0","volume":"161","author":"DH Zermann","year":"1999","unstructured":"Zermann, D. H., Ishigooka, M., Doggweiler, R. & Schmidt, R. A. Neurourological insights into the etiology of genitourinary pain in men. J. Urol. 161, 903\u2013908 (1999).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/01.ju.0000161609.31185.d5","volume":"174","author":"RU Anderson","year":"2005","unstructured":"Anderson, R. U., Wise, D., Sawyer, T. & Chan, C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J. Urol. 174, 155\u2013160 (2005).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR39","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.juro.2006.06.010","volume":"176","author":"RU Anderson","year":"2006","unstructured":"Anderson, R. U., Wise, D., Sawyer, T. & Chan, C. A. Sexual dysfunction in men with chronic prostatitis\/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J. Urol. 176, 1534\u20131539 (2006).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR40","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0022-5347(05)65539-5","volume":"166","author":"JM Weiss","year":"2001","unstructured":"Weiss, J. M. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J. Urol. 166, 2226\u20132231 (2001).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR41","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.juro.2009.08.033","volume":"182","author":"RU Anderson","year":"2009","unstructured":"Anderson, R. U., Sawyer, T., Wise, D., Morey, A. & Nathanson, B. H. Painful myofascial trigger points and pain sites in men with chronic prostatitis\/chronic pelvic pain syndrome. J. Urol. 182, 2753\u20132758 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2009.04.022","volume":"182","author":"MP FitzGerald","year":"2009","unstructured":"FitzGerald, M. P. et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J. Urol. 182, 570\u2013580 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0090-4295(00)00796-2","volume":"56","author":"JQ Clemens","year":"2000","unstructured":"Clemens, J. Q. et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 56, 951\u2013955 (2000).","journal-title":"Urology"},{"key":"BFnrurol20104_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0090-4295(02)02390-7","volume":"60","author":"RB Nadler","year":"2002","unstructured":"Nadler, R. B. Bladder training biofeedback and pelvic floor myalgia. Urology 60, 42\u201344 (2002).","journal-title":"Urology"},{"key":"BFnrurol20104_CR45","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.eururo.2004.12.014","volume":"47","author":"EB Cornel","year":"2005","unstructured":"Cornel, E. B., van Haarst, E. P., Schaarsberg, R. W. & Geels, J. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur. Urol. 47, 607\u2013611 (2005).","journal-title":"Eur. Urol."},{"key":"BFnrurol20104_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S0090-4295(02)01704-1","volume":"60","author":"MJ Leskinen","year":"2002","unstructured":"Leskinen, M. J., Kilponen, A., Lukkarinen, O. & Tammela, T. L. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology 60, 300\u2013304 (2002).","journal-title":"Urology"},{"key":"BFnrurol20104_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.urology.2004.07.016","volume":"64","author":"C Kastner","year":"2004","unstructured":"Kastner, C., Hochreiter, W., Huidobro, C., Cabezas, J. & Miller, P. Cooled transurethral microwave thermotherapy for intractable chronic prostatitis--results of a pilot study after 1 year. Urology 64, 1149\u20131154 (2004).","journal-title":"Urology"},{"key":"BFnrurol20104_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-5347(09)60354-2","volume":"181","author":"M Pontari","year":"2009","unstructured":"Pontari, M. et al. A randomized placebo-controlled multicenter trial of pregabalin for the treatment of men with chronic prostatitis\/chronic pelvic pain syndrome [abstract 340]. J. Urol. 181, 123 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1191\/0269216304pm845ra","volume":"18","author":"MI Bennett","year":"2004","unstructured":"Bennett, M. I. & Simpson, K. H. Gabapentin in the treatment of neuropathic pain. Palliat. Med. 18, 5\u201311 (2004).","journal-title":"Palliat. Med."},{"key":"BFnrurol20104_CR50","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","volume":"57","author":"MA Rose","year":"2002","unstructured":"Rose, M. A. & Kam, P. C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 57, 451\u2013462 (2002).","journal-title":"Anaesthesia"},{"key":"BFnrurol20104_CR51","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.amjopharm.2005.12.008","volume":"3","author":"DR Guay","year":"2005","unstructured":"Guay, D. R. Pregabalin in neuropathic pain: a more \u201cpharmaceutically elegant\u201d gabapentin? Am. J. Geriatr. Pharmacother. 3, 274\u2013287 (2005).","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"BFnrurol20104_CR52","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1213\/01.ane.0000287643.13410.5e","volume":"105","author":"NM Gajraj","year":"2007","unstructured":"Gajraj, N. M. Pregabalin: its pharmacology and use in pain management. Anesth. Analg. 105, 1805\u20131815 (2007).","journal-title":"Anesth. Analg."},{"key":"BFnrurol20104_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00044011-200929030-00006","volume":"29","author":"S Chiechio","year":"2009","unstructured":"Chiechio, S. et al. Pregabalin in the treatment of chronic pain: an overview. Clin. Drug Investig. 29, 203\u2013213 (2009).","journal-title":"Clin. Drug Investig."},{"key":"BFnrurol20104_CR54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/bja\/ael344","volume":"98","author":"BA Chizh","year":"2007","unstructured":"Chizh, B. A. et al. Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br. J. Anaesth. 98, 246\u2013254 (2007).","journal-title":"Br. J. Anaesth."},{"key":"BFnrurol20104_CR55","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1097\/00000542-200412000-00021","volume":"101","author":"H Gottrup","year":"2004","unstructured":"Gottrup, H. et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 101, 1400\u20131408 (2004).","journal-title":"Anesthesiology"},{"key":"BFnrurol20104_CR56","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","volume":"60","author":"RH Dworkin","year":"2003","unstructured":"Dworkin, R. H. et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60, 1524\u20131534 (2003).","journal-title":"Arch. Neurol."},{"key":"BFnrurol20104_CR57","unstructured":"Pfizer prescription products. LYRICA\u00ae US physician prescribing information [online] , (2010)."},{"key":"BFnrurol20104_CR58","unstructured":"Pfizer prescription products. Neurontin\u00ae US physician prescribing information [online] , (2010)."},{"key":"BFnrurol20104_CR59","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.2165\/00003495-200868150-00009","volume":"68","author":"KA Lyseng-Williamson","year":"2008","unstructured":"Lyseng-Williamson, K. A. & Siddiqui, M. A. Pregabalin: a review of its use in fibromyalgia. Drugs 68, 2205\u20132223 (2008).","journal-title":"Drugs"},{"key":"BFnrurol20104_CR60","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","volume":"27","author":"JA Mic\u00f3","year":"2006","unstructured":"Mic\u00f3, J. A., Ardid, D., Berrocoso, E. & Eschalier, A. Antidepressants and pain. Trends Pharmacol. Sci. 27, 348\u2013354 (2006).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrurol20104_CR61","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U","volume":"42","author":"I Yaron","year":"1999","unstructured":"Yaron, I. et al. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 42, 2561\u20132568 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnrurol20104_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","volume":"96","author":"SH Sindrup","year":"2005","unstructured":"Sindrup, S. H., Otto, M., Finnerup, N. B. & Jensen, T. S. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol. 96, 399\u2013409 (2005).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"BFnrurol20104_CR63","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0014-2999(00)00460-X","volume":"401","author":"JH Song","year":"2000","unstructured":"Song, J. H., Ham, S. S., Shin, Y. K. & Lee, C. S. Amitriptyline modulation of Na(+) channels in rat dorsal root ganglion neurons. Eur. J. Pharmacol. 401, 297\u2013305 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrurol20104_CR64","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.biopsych.2007.06.016","volume":"63","author":"M Benbouzid","year":"2008","unstructured":"Benbouzid, M. et al. Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol. Psychiatry 63, 633\u2013636 (2008).","journal-title":"Biol. Psychiatry"},{"key":"BFnrurol20104_CR65","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.chembiol.2009.05.010","volume":"16","author":"SW Jang","year":"2009","unstructured":"Jang, S. W. et al. Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA\/TrkB heterodimerization and has potent neurotrophic activity. Chem. Biol. 16, 644\u2013656 (2009).","journal-title":"Chem. Biol."},{"key":"BFnrurol20104_CR66","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2165\/0003495-200868180-00007","volume":"68","author":"B Verdu","year":"2008","unstructured":"Verdu, B., Decosterd, I., Buclin, T., Stiefel, F. & Berney, A. Antidepressants for the treatment of chronic pain. Drugs 68, 2611\u20132632 (2008).","journal-title":"Drugs"},{"key":"BFnrurol20104_CR67","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00508-005-0464-2","volume":"117","author":"SM Sator-Katzenschlager","year":"2005","unstructured":"Sator-Katzenschlager, S. M. et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien. Klin. Wochenschr. 117, 761\u2013768 (2005).","journal-title":"Wien. Klin. Wochenschr."},{"key":"BFnrurol20104_CR68","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1001\/archinte.159.16.1931","volume":"159","author":"CM Morello","year":"1999","unstructured":"Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F. & Sahagian, G. A. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch. Intern. Med. 159, 1931\u20131937 (1999).","journal-title":"Arch. Intern. Med."},{"key":"BFnrurol20104_CR69","unstructured":"Hanno, P. A new look at the use of amitriptyline for the treatment of interstitial cystitis: results of an NIH clinical trial. Presented at the 2009 Annual Meeting of the American Urological Association."},{"key":"BFnrurol20104_CR70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1517\/14740330802528420","volume":"8","author":"H Kavirajan","year":"2009","unstructured":"Kavirajan, H. Memantine: a comprehensive review of safety and efficacy. Expert Opin. Drug Saf. 8, 89\u2013109 (2009).","journal-title":"Expert Opin. Drug Saf."},{"key":"BFnrurol20104_CR71","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","volume":"97","author":"HS Chen","year":"2006","unstructured":"Chen, H. S. & Lipton, S. A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97, 1611\u20131626 (2006).","journal-title":"J. Neurochem."},{"key":"BFnrurol20104_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","volume":"1","author":"SA Lipton","year":"2004","unstructured":"Lipton, S. A. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx 1, 101\u2013110 (2004).","journal-title":"NeuroRx"},{"key":"BFnrurol20104_CR73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0014-2999(01)01307-3","volume":"429","author":"CG Parsons","year":"2001","unstructured":"Parsons, C. G. NMDA receptors as targets for drug action in neuropathic pain. Eur. J. Pharmacol. 429, 71\u201378 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrurol20104_CR74","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0006-8993(92)90193-D","volume":"598","author":"J Mao","year":"1992","unstructured":"Mao, J., Price, D. D., Hayes, R. L., Lu, J. & Mayer, D. J. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res. 598, 271\u2013278 (1992).","journal-title":"Brain Res."},{"key":"BFnrurol20104_CR75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0304-3940(95)11975-3","volume":"198","author":"J Mao","year":"1995","unstructured":"Mao, J., Price, D. D., Phillips, L. L., Lu, J. & Mayer, D. J. Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci. Lett. 198, 75\u201378 (1995).","journal-title":"Neurosci. Lett."},{"key":"BFnrurol20104_CR76","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpain.2005.02.003","volume":"6","author":"BD Fischer","year":"2005","unstructured":"Fischer, B. D., Carrigan, K. A. & Dykstra, L. A. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J. Pain 6, 425\u2013433 (2005).","journal-title":"J. Pain"},{"key":"BFnrurol20104_CR77","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-5347(09)60353-0","volume":"181","author":"JD Dimitrakov","year":"2009","unstructured":"Dimitrakov, J. D., Chitalov, J. & Dechev, I. Memantine in the alleviation of symptoms of chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled trial [abstract 339]. J. Urol. 181, 123 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/NDT.S4048","volume":"5","author":"RJ van Marum","year":"2009","unstructured":"van Marum, R. J. Update on the use of memantine in Alzheimer's disease. Neuropsychiatr. Dis. Treat. 5, 237\u2013247 (2009).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"BFnrurol20104_CR79","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.urology.2006.04.013","volume":"68","author":"JC Nickel","year":"2006","unstructured":"Nickel, J. C. Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th World Congress on Pain. Urology 68, 697\u2013701 (2006).","journal-title":"Urology"},{"key":"BFnrurol20104_CR80","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/jama.293.24.3043","volume":"293","author":"E Eisenberg","year":"2005","unstructured":"Eisenberg, E., McNicol, E. D. & Carr, D. B. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 293, 3043\u20133052 (2005).","journal-title":"JAMA"},{"key":"BFnrurol20104_CR81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ejpain.2005.10.007","volume":"10","author":"E Eisenberg","year":"2006","unstructured":"Eisenberg, E., McNicol, E. D. & Carr, D. B. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur. J. Pain 10, 667\u2013676 (2006).","journal-title":"Eur. J. Pain"},{"key":"BFnrurol20104_CR82","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0074-7742(09)85019-8","volume":"85","author":"H Mizoguchi","year":"2009","unstructured":"Mizoguchi, H., Watanabe, C., Yonezawa, A. & Sakurada, S. New therapy for neuropathic pain. Int. Rev. Neurobiol. 85, 249\u2013260 (2009).","journal-title":"Int. Rev. Neurobiol."},{"key":"BFnrurol20104_CR83","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0090-4295(01)01597-7","volume":"59","author":"LJ Miller","year":"2002","unstructured":"Miller, L. J. et al. Nerve growth factor and chronic prostatitis\/chronic pelvic pain syndrome. Urology 59, 603\u2013608 (2002).","journal-title":"Urology"},{"key":"BFnrurol20104_CR84","doi-asserted-by":"publisher","first-page":"R1268","DOI":"10.1152\/ajpregu.00836.2007","volume":"294","author":"CN Rudick","year":"2008","unstructured":"Rudick, C. N., Schaeffer, A. J. & Thumbikat, P. Experimental autoimmune prostatitis induces chronic pelvic pain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1268\u2013R1275 (2008).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrurol20104_CR85","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.juro.2007.07.120","volume":"180","author":"YC Chuang","year":"2008","unstructured":"Chuang, Y. C. et al. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J. Urol. 180, 742\u2013748 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR86","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.juro.2008.01.028","volume":"179","author":"NV Desireddi","year":"2008","unstructured":"Desireddi, N. V. et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J. Urol. 179, 1857\u20131862 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR87","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.eururo.2006.07.016","volume":"51","author":"G Penna","year":"2007","unstructured":"Penna, G. et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis\/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur. Urol. 51, 524\u2013533 (2007).","journal-title":"Eur. Urol."},{"key":"BFnrurol20104_CR88","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0090-4295(01)01138-4","volume":"58","author":"JD Dimitrakov","year":"2001","unstructured":"Dimitrakov, J. D. A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology 58, 281 (2001).","journal-title":"Urology"},{"key":"BFnrurol20104_CR89","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.juro.2008.11.119","volume":"181","author":"J Dimitrakov","year":"2009","unstructured":"Dimitrakov, J. & Guthrie, D. Genetics and phenotyping of urological chronic pelvic pain syndrome. J. Urol. 181, 1550\u20131557 (2009).","journal-title":"J. Urol."},{"key":"BFnrurol20104_CR90","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11934-996-0013-1","volume":"7","author":"MA Pontari","year":"2006","unstructured":"Pontari, M. A. Chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis: are they related? Curr. Urol. Rep. 7, 329\u2013334 (2006).","journal-title":"Curr. Urol. Rep."},{"key":"BFnrurol20104_CR91","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.urology.2007.09.025","volume":"71","author":"J Dimitrakov","year":"2008","unstructured":"Dimitrakov, J. et al. Adrenocortical hormone abnormalities in men with chronic prostatitis\/chronic pelvic pain syndrome. Urology 71, 261\u2013266 (2008).","journal-title":"Urology"},{"key":"BFnrurol20104_CR92","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1213\/01.ane.0000198333.22687.a6","volume":"102","author":"PJ Siddall","year":"2006","unstructured":"Siddall, P. J. et al. Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report. Anesth. Analg. 102, 1164\u20131168 (2006).","journal-title":"Anesth. Analg."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2010.4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T17:00:44Z","timestamp":1711213244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2010.4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["BFnrurol20104"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2010.4","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}